Erasca (ERAS) Payables (2020 - 2026)

Erasca (ERAS) reported Payables of $2.2 million for Q1 2026, down 4.38% on a YoY basis from $2.3 million in Q1 2025, and up 120.49% quarter-over-quarter from $981000.0 in Q4 2025.

Erasca (ERAS) Payables (2020 - 2026) Analysis & Trends

Erasca has reported Payables for 7 years, with the latest figure at $2.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Payables fell 4.38% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 4.38% YoY), and the FY2025 full-year result was $981000.0, up 109.62% from the prior year.
  • Payables for Q1 2026 stood at $2.2 million, up from $981000.0 in the prior quarter.
  • The five-year high for Payables was $23.0 million in Q4 2022, with the low at $468000.0 in Q4 2024.
  • Historically, Payables has averaged $3.8 million across 5 years, with a median of $2.4 million in 2024.
  • Annual changes were most pronounced in 2022 — Payables soared 392.82% — and 2023, when it slumped 91.32%.
  • Erasca's Payables stood at $23.0 million in 2022, then tumbled by 91.32% to $2.0 million in 2023, then sank by 76.6% to $468000.0 in 2024, then soared by 109.62% to $981000.0 in 2025, then jumped by 120.49% to $2.2 million in 2026.
  • The last three Payables figures came in at $2.2 million (Q1 2026), $981000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 300,549.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.69 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Erasca 4.16 Bn 3.92 Bn - 2.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.16 Mn
Dec 31, 2025 981,000.00
Sep 30, 2025 3.03 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 2.26 Mn
Dec 31, 2024 468,000.00
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.14 Mn
Mar 31, 2024 2.63 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 3.70 Mn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 3.35 Mn
Dec 31, 2022 23.05 Mn
Sep 30, 2022 4.32 Mn
Jun 30, 2022 2.29 Mn
Mar 31, 2022 4.71 Mn
Dec 31, 2021 4.68 Mn
Sep 30, 2021 1.32 Mn
Jun 30, 2021 1.51 Mn